A phase II study of laquinimod in Crohn's disease.

Objective: Laquinimod is an oral therapeutic agent under investigation for the treatment of Crohn's disease (CD), Huntington's disease, lupus nephritis and multiple sclerosis. This dose escalation study evaluated the safety and efficacy of laquinimod as induction therapy in patients with active moderate-severe CD.

Design: Multicentre, double-blind, sequential-cohort, randomised controlled trial with laquinimod doses of 0.

Virtual reality-enhanced ultrasound guidance for atrial ablation: in vitro epicardial study.

In an effort to reduce morbidity of cardiac interventions, minimizing invasiveness inevitably leads to limited visual access to the surgical targets. To address these limitations, we provide the surgeons with a robust visualization environment that integrates interventional ultrasound imaging augmented with pre-operative anatomical models and virtual surgical instruments within a virtual reality environment. Here we present an in vitro study on a cardiac phantom that mimics an ablation therapy procedure, which allows us to assess the feasibility of our surgical system in comparison to traditional intra-operative ultrasound imaging.

Characterization of content and chromatographic forms of neuropeptides in purified nerve varicosities prepared from guinea pig myenteric plexus.

Partially purified nerve varicosities (PV) prepared from guinea pig ileal myenteric plexus were found to contain, by radioimmunoassay, gastrin-releasing polypeptide (GRP), substance P (SP), galanin, Leu-enkephalin (LE), Met-enkephalin (ME), and vasoactive intestinal polypeptide (VIP). SP was present in the highest concentration followed by, in descending order, ME, LE, VIP, GRP and galanin. On reverse-phase HPLC, SP-, LE- and ME-like immunoreactivity in the PV preparation eluted at retention times similar to their synthetic analogues, galanin-like immunoreactivity eluted at a retention time different from that of synthetic porcine galanin and VIP-like immunoreactivity eluted at the retention time of synthetic guinea pig VIP.